Apyx Medical Corp (BOV.MU)
| Previous close | 1.3300 |
| Open | 1.3300 |
| Bid | 1.2900 x N/A |
| Ask | 1.3300 x N/A |
| Day's range | 1.3300 - 1.3300 |
| 52-week range | 1.1600 - 6.8500 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
CLEARWATER, Fla., April 25, 2024--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2024 will be released before the market opens on Thursday, May 9th.
- Business Wire
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
CLEARWATER, Fla., April 11, 2024--Apyx® Medical Corporation (NASDAQ:APYX) (the "Apyx Medical"; "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, is pleased to announce the Renuvion Users’ Summit is taking place in Las Vegas from April 12-13, 2024.
Simply Wall St.Downgrade: Here's How Analysts See Apyx Medical Corporation (NASDAQ:APYX) Performing In The Near Term
One thing we could say about the analysts on Apyx Medical Corporation ( NASDAQ:APYX ) - they aren't optimistic, having...
